Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5464)
aTyr Pharma, Inc. (ATYR)
Broadfoot Jill Marie — Chief Financial Officer
Shares
1,558
Price
$0.98
Total Value
$1.52K
Shares Held After
37,296
% of Holdings
4.0%
aTyr Pharma, Inc. (ATYR)
DENYES NANCY — General Counsel
Shares
1,118
Price
$0.98
Total Value
$1.09K
Shares Held After
33,124
% of Holdings
3.3%
aTyr Pharma, Inc. (ATYR)
Shukla Sanjay — Director
Shares
3,745
Price
$0.98
Total Value
$3.66K
Shares Held After
153,553
% of Holdings
2.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
9,794
Price
$25.81
Total Value
$252.75K
Shares Held After
80,651
% of Holdings
10.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
2,602
Price
$45.02
Total Value
$117.14K
Shares Held After
12,546
% of Holdings
17.2%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$1.13
Total Value
$5.65K
Shares Held After
273,866
% of Holdings
1.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,087
Price
$43.29
Total Value
$47.06K
Shares Held After
22,885
% of Holdings
4.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
19,076
Price
$43.29
Total Value
$825.85K
Shares Held After
164,580
% of Holdings
10.4%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
40,000
Price
$0.03
Total Value
$1.34K
Shares Held After
30,341,968
% of Holdings
0.1%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
3,217
Price
$19.69
Total Value
$63.34K
Shares Held After
55,588
% of Holdings
5.5%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
1,608
Price
$19.69
Total Value
$31.66K
Shares Held After
51,326
% of Holdings
3.0%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
2,654
Price
$19.69
Total Value
$52.26K
Shares Held After
52,934
% of Holdings
4.8%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
220,000
Price
$4.20
Total Value
$924.00K
Shares Held After
6,429,863
% of Holdings
3.3%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
2,971
Price
$41.97
Total Value
$124.68K
Shares Held After
22,320
% of Holdings
11.7%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,689
Price
$41.25
Total Value
$275.93K
Shares Held After
25,291
% of Holdings
20.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,790
Price
$76.73
Total Value
$597.76K
Shares Held After
708,719
% of Holdings
1.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,659
Price
$75.94
Total Value
$733.54K
Shares Held After
716,509
% of Holdings
1.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,551
Price
$74.88
Total Value
$191.02K
Shares Held After
726,168
% of Holdings
0.4%
ProMIS Neurosciences Inc. (PMN)
ABG Management Ltd. — 10% Owner
Shares
700,741
Price
$12.13
Total Value
$8.50M
Shares Held After
943,090
% of Holdings
74.3%
HCA Healthcare, Inc. (HCA)
Cuffe Michael S. — EVP and Chief Clinical Officer
Shares
1,500
Price
$498.09
Total Value
$747.14K
Shares Held After
30,003
% of Holdings
4.8%
HCA Healthcare, Inc. (HCA)
HAZEN SAMUEL N — Director
Shares
120
Price
$497.18
Total Value
$59.66K
Shares Held After
32,276
% of Holdings
0.4%
HCA Healthcare, Inc. (HCA)
HAZEN SAMUEL N — Director
Shares
4,293
Price
$498.12
Total Value
$2.14M
Shares Held After
32,396
% of Holdings
11.7%
HCA Healthcare, Inc. (HCA)
HAZEN SAMUEL N — Director
Shares
5,162
Price
$498.80
Total Value
$2.57M
Shares Held After
36,689
% of Holdings
12.3%
HCA Healthcare, Inc. (HCA)
HAZEN SAMUEL N — Director
Shares
6,189
Price
$500.02
Total Value
$3.09M
Shares Held After
41,851
% of Holdings
12.9%
HCA Healthcare, Inc. (HCA)
HAZEN SAMUEL N — Director
Shares
7,395
Price
$500.69
Total Value
$3.70M
Shares Held After
48,040
% of Holdings
13.3%
HCA Healthcare, Inc. (HCA)
HAZEN SAMUEL N — Director
Shares
5,002
Price
$502.15
Total Value
$2.51M
Shares Held After
55,435
% of Holdings
8.3%
HCA Healthcare, Inc. (HCA)
HAZEN SAMUEL N — Director
Shares
14,716
Price
$502.95
Total Value
$7.40M
Shares Held After
60,437
% of Holdings
19.6%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$40.87
Total Value
$817.33K
Shares Held After
1,235
% of Holdings
94.2%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
1,170
Price
$15.25
Total Value
$17.84K
Shares Held After
156,052
% of Holdings
0.7%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
3,000
Price
$14.82
Total Value
$44.47K
Shares Held After
157,222
% of Holdings
1.9%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
5,001
Price
$46.58
Total Value
$232.93K
Shares Held After
869,312
% of Holdings
0.6%
Twist Bioscience Corp (TWST)
WERNER ROBERT F. — Chief Accounting Officer
Shares
175
Price
$46.58
Total Value
$8.15K
Shares Held After
65,738
% of Holdings
0.3%
Twist Bioscience Corp (TWST)
Green Paula — SVP of Human Resources
Shares
1,194
Price
$46.58
Total Value
$55.61K
Shares Held After
165,445
% of Holdings
0.7%
Twist Bioscience Corp (TWST)
Cho Dennis — Senior Vice President, Chief Legal Officer & Corporate Secretary
Shares
1,099
Price
$46.58
Total Value
$51.19K
Shares Held After
143,581
% of Holdings
0.8%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
2,705
Price
$46.58
Total Value
$125.99K
Shares Held After
307,788
% of Holdings
0.9%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
323
Price
$1.82
Total Value
$588.51
Shares Held After
514,551
% of Holdings
0.1%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
3,200
Price
$39.91
Total Value
$127.72K
Shares Held After
84,515
% of Holdings
3.6%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
2,153
Price
$20.00
Total Value
$43.06K
Shares Held After
18,900
% of Holdings
10.2%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
3,403
Price
$20.00
Total Value
$68.06K
Shares Held After
18,900
% of Holdings
15.3%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,559
Price
$4.10
Total Value
$22.79K
Shares Held After
550,000
% of Holdings
1.0%
Spero Therapeutics, Inc. (SPRO)
Keutzer Timothy — Chief Operating Officer
Shares
24,224
Price
$2.14
Total Value
$51.84K
Shares Held After
764,629
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
1
Price
$18.00
Total Value
$18.00
Shares Held After
358,233
% of Holdings
0.0%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
4,725
Price
$230.77
Total Value
$1.09M
Shares Held After
123,156
% of Holdings
3.7%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
4,971
Price
$227.45
Total Value
$1.13M
Shares Held After
52,120
% of Holdings
8.7%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
700
Price
$225.25
Total Value
$157.67K
Shares Held After
57,091
% of Holdings
1.2%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
1,268
Price
$230.77
Total Value
$292.61K
Shares Held After
57,791
% of Holdings
2.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,639
Price
$230.77
Total Value
$378.23K
Shares Held After
137,847
% of Holdings
1.2%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
2,415
Price
$231.14
Total Value
$558.20K
Shares Held After
178,081
% of Holdings
1.3%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
1,179
Price
$230.77
Total Value
$272.08K
Shares Held After
180,496
% of Holdings
0.6%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,334
Price
$230.77
Total Value
$307.84K
Shares Held After
223,813
% of Holdings
0.6%
Showing 3151–3200 of 5464 transactions (page 64 of 110)